NUCLEAR ZINC IN METASTATIC TUMORS OF PROSTATIC ADENOCARCINOMA
Ziad M. Bataineh
Department of Anatomy, Faculty of
Medicine,
JordanUniversity
of Science
and Technology, Irbid-2211O, Jordan
Abstract
The zinc-binding proteins regulate genes, which play an important role in cell
differentiation and proliferation. Moreover, zinc is involved in DNA and RNA
transcription and replication. Also, zinc was elevated and decreased in benign
prostatic hyperplasia and adenocarcinoma of the prostate, respectively. The
hypothesis that the behaviours of metastatic tumors of prostate might affect the
nuclear zinc concentration was postulated, since zinc have been demonstrated in
the nuclei of normal rat, and dog prostate gland. The X-ray microanalysis
technique was used to detect and quantitate zinc in nuclei of metastatic tumor
cells of porstatic adenocarcinoma R-33271-J cell line, in skin, liver and lung.
S.C. implants, or 1.V. infusion of about 106 cells were used to establish
metastatic tumors. It was found that zinc concentration in euchromatin and
heterochromatin was higher in metastatic tumors of l.V. treated group. However,
there was a variation in zinc concentration across the treatment and across the
organs. From these results, it was suggested that the route of metastasis could
affect nuclear sequestration of zinc. The euchromatin/heterochromatin zinc
concentration ration and zinc concentration could be used as an estimated factor
in diagnosis of prostatic tumor metastasis.
Key words:
X-ray micro-analysis, protein expression, proliferation, RNA, DNA, Zn.